Holen Sie sich die Stockscreener-App
7.075
1.14%
0.075
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
Chartists See Breakout Potential in Abeona Therapeutics Inc.July 2025 WrapUp & High Accuracy Swing Entry Alerts - newsyoung.net
Institutional scanner results for Abeona Therapeutics Inc.2025 Winners & Losers & AI Driven Stock Reports - Newser
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q2 2025 Earnings Call Transcript - Insider Monkey
What to expect from Abeona Therapeutics Inc. in the next 30 daysJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
Using economic indicators to assess Abeona Therapeutics Inc. potential2025 Technical Overview & Stock Portfolio Risk Management - Newser
Backtesting results for Abeona Therapeutics Inc. trading strategiesQuarterly Market Review & Daily Profit Maximizing Trade Tips - Newser
Leading vs lagging indicators on Abeona Therapeutics Inc. performanceQuarterly Market Summary & Verified Chart Pattern Signals - Newser
Real time breakdown of Abeona Therapeutics Inc. stock performancePortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
What MACD and RSI say about Abeona Therapeutics Inc.July 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
What’s the recovery path for long term holders of Abeona Therapeutics Inc.2025 Breakouts & Breakdowns & Advanced Technical Signal Analysis - Newser
Abeona Therapeutics Inc.’s volatility index tracking explained2025 Geopolitical Influence & AI Driven Price Predictions - Newser
What the charts say about Abeona Therapeutics Inc. todayShare Buyback & AI Powered Market Entry Ideas - Newser
How to forecast Abeona Therapeutics Inc. trends using time series2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
What technical models suggest about Abeona Therapeutics Inc.’s comebackStop Loss & Weekly High Return Opportunities - Newser
Abeona Therapeutics (ABEO) Gets a Buy from H.C. Wainwright - The Globe and Mail
ABEO: First Patient Treatment with Zevaskyn Expected in 3Q25 - Research Tree
Abeona Therapeutics Inc. stock trend outlook and recovery pathTrade Signal Summary & Capital Efficient Trading Techniques - Newser
Can Abeona Therapeutics Inc. maintain sales growthPortfolio Gains Summary & Accurate Intraday Trading Signals - thegnnews.com
Will Abeona Therapeutics Inc. continue its uptrendJuly 2025 Fed Impact & Daily Stock Trend Reports - Newser
Abeona Therapeutics Inc. stock chart pattern explainedEarnings Performance Report & Weekly Sector Rotation Insights - Newser
Abeona Therapeutics Executives Offload Stock Amid Financial Turnaround - AInvest
Top Executives Offload Abeona Therapeutics Stock in Major Transactions - TipRanks
Abeona Therapeutics director Crombez sells $33k in shares - Investing.com
Abeona Therapeutics director Crombez sells $33k in shares By Investing.com - Investing.com South Africa
Abeona Therapeutics CFO sells $110k in stock - Investing.com India
Abeona Therapeutics CFO sells $110k in stock By Investing.com - Investing.com UK
Abeona Therapeutics: AAV204 Capsid Licensing as a New Growth Engine - AInvest
Abeona Therapeutics: AAV204 Capsid Could Be Next Growth Prospect Beyond Zevaskyn (ABEO) - Seeking Alpha
Abeona Therapeutics price target raised to $20 from $19 at Oppenheimer - TipRanks
How to read the order book for Abeona Therapeutics Inc.Market Risk Analysis & Reliable Price Action Trade Plans - Newser
Oppenheimer Adjusts Abeona Therapeutics Price Target to $20 From $19, Maintains Outperform Rating - MarketScreener
Earnings call transcript: Abeona Therapeutics Q2 2025 reports unexpected profit - Investing.com
Abeona Therapeutics: Q2 Earnings Snapshot - Stamford Advocate
Screener Results Flag Abeona Therapeutics Inc. as OversoldJuly 2025 PreEarnings & AI Forecasted Stock Moves - beatles.ru
Abeona Posts Q2 Profit on Asset Sale - AOL.com
Abeona Therapeutics Reports Strong Financial Turnaround - TipRanks
Abeona Therapeutics Inc. stock outlook for YEARPortfolio Growth Summary & Stepwise Trade Execution Plans - Newser
Abeona Therapeutics Inc. Breaks Losing Streak — Is the Trend ReversingCEO Change & AI Enhanced Trading Alerts - beatles.ru
Abeona Therapeutics' Q2 2025 Earnings: A Catalyst-Driven Path to Commercialization and Profitability - AInvest
Transcript : Abeona Therapeutics Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Abeona Therapeutics reports Q2 EPS ($1.71) vs (26c) last year - TipRanks
Abeona Therapeutics Shakes Off Losses With A Surprise Profit - Finimize
Abeona Therapeutics shares rise 6.71% premarket after reporting Q2 net income of $108.8 million, beating Wall Street expectations. - AInvest
Abeona Therapeutics Receives FDA Approval for ZEVASKYN™: First Autologous Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa with Launch Expected in 2025 - Quiver Quantitative
Abeona Therapeutics Q2 net income beats estimates on PRV sale, sees profitability in H1 2026 - MarketScreener
ABEONA THERAPEUTICS INC. SEC 10-Q Report - TradingView
Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates - GlobeNewswire
0.95%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):